Cargando…

Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

BACKGROUND: At present, ursodeoxycholic acid (UDCA) is internationally recognized as a therapeutic drug in clinic. However, about 40% Primary Biliary Cholangitis (PBC) patients are poor responders to UDCA. It has been demonstrated that Transcutaneous Neuromodulation (TN) can be involved in gut motil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hui, Yang, Hang, Wang, Lixia, Shi, Honggang, Liu, Bojia, Lin, Xue, Chang, Qingyong, Chen, Jiande D. Z., Duan, Zhijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395375/ https://www.ncbi.nlm.nih.gov/pubmed/32738911 http://dx.doi.org/10.1186/s12906-020-03036-w

Ejemplares similares

Home-Based Transcutaneous Neuromodulation Improved Constipation via Modulating Gastrointestinal Hormones and Bile Acids
por: Ge, Zhenyang, et al.
Publicado: (2018)

Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis
por: Martinez-Gili, Laura, et al.
Publicado: (2023)

Transcutaneous Neuromodulation at Posterior Tibial Nerve and ST36 for Chronic Constipation
por: Zhang, Nina, et al.
Publicado: (2014)

Predictive Model of Ursodeoxycholic Acid Treatment Response in Primary Biliary Cholangitis
por: Shu, Yanyun, et al.
Publicado: (2021)

Body mass index contributes to sympathovagal imbalance in prehypertensives
por: Pal, Gopal Krushna, et al.
Publicado: (2012)

Association of Sympathovagal Imbalance with Cardiovascular Risks in Overt Hypothyroidism
por: Syamsunder, Avupati Naga, et al.
Publicado: (2013)

Association of cardiovascular risks with sympathovagal imbalance in rheumatoid arthritis
por: Pal, G.K.
Publicado: (2012)

Effect of virtual reality-simulated exercise on sympathovagal balance
por: Ahmed, Sheaza, et al.
Publicado: (2020)

Combination therapy of obeticholic acid and ursodeoxycholic acid in patients with primary biliary cholangitis who respond incompletely to ursodeoxycholic acid: a systematic review
por: Li, Xuan, et al.
Publicado: (2020)

High neutrophil-lymphocyte ratio indicates a worse response to ursodeoxycholic acid in primary biliary cholangitis: a retrospective cohort study
por: Zhu, Huiling, et al.
Publicado: (2023)

Altered sympathovagal balance and pain hypersensitivity in TNBS-induced colitis
por: Ciesielczyk, Katarzyna, et al.
Publicado: (2016)

Depressed sympathovagal modulation indicates sepsis in patients with suspected infection
por: Hsu, Ching-Tang, et al.
Publicado: (2020)

Is the Association Between Education and Sympathovagal Balance Mediated by Chronic Stressors?
por: van Nieuwenhuizen, Benjamin P., et al.
Publicado: (2021)

Imbalance of Peripheral Temperature, Sympathovagal, and Cytokine Profile in Long COVID
por: Neves, Pablo Fabiano Moura das, et al.
Publicado: (2023)

Transcutaneous Spinal Neuromodulation Reorganizes Neural Networks in Patients with Cerebral Palsy
por: Gad, Parag, et al.
Publicado: (2021)

A decline of LAMP- 2 predicts ursodeoxycholic acid response in primary biliary cirrhosis
por: Wang, Lu, et al.
Publicado: (2015)

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
por: Cançado, Guilherme Grossi Lopes, et al.
Publicado: (2022)

Transcutaneous Spinal Cord Stimulation: Advances in an Emerging Non-Invasive Strategy for Neuromodulation
por: Hofstoetter, Ursula S., et al.
Publicado: (2022)

Parasympathetic control of gastrointestinal motility and cross-branch actions of parasympathetic neuromodulation
por: Chen, Jiande DZ
Publicado: (2023)

Ursodeoxycholic Acid Is Conjugated with Taurine to Promote Secretin-Stimulated Biliary Hydrocholeresis in the Normal Rat
por: Úriz, Miriam, et al.
Publicado: (2011)

Ursodeoxycholic Acid Improves Bilirubin but Not Albumin in Primary Biliary Cirrhosis: Further Evidence for Nonefficacy
por: Tsochatzis, Emmanuel A., et al.
Publicado: (2013)

Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis
por: Zimmer, Vincent, et al.
Publicado: (2016)

A Systems Model for Ursodeoxycholic Acid Metabolism in Healthy and Patients With Primary Biliary Cirrhosis
por: Zuo, P, et al.
Publicado: (2016)

A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
por: Li, Chunlei, et al.
Publicado: (2022)

Emerging Noninvasive Neuromodulation Methods for Functional Gastrointestinal Diseases
por: DZ Chen, Jiande, et al.
Publicado: (2023)

Transcutaneous Electrical Spinal Cord Neuromodulator (TESCoN) Improves Symptoms of Overactive Bladder
por: Kreydin, Evgeniy, et al.
Publicado: (2020)

Transcutaneous Neuromodulation for Constipation and Fecal Incontinence in Children: A Systematic Review and Meta-Analysis
por: Correia, Ronny Rodrigues, et al.
Publicado: (2023)

Sympathovagal Imbalance in Prehypertensive Offspring of Two Parents versus One Parent Hypertensive
por: Pal, G. K., et al.
Publicado: (2011)

The Effect of Ivabradine on the Heart Rate and Sympathovagal Balance in Postural Tachycardia Syndrome Patients
por: Barzilai, Merav, et al.
Publicado: (2015)

Sympathovagal Balance and Body Shape Index in Elite and Amateur Athletes: The Relationship Unraveled
por: Kothari, Ruchi, et al.
Publicado: (2023)

External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid
por: Cheung, Angela C., et al.
Publicado: (2018)

Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis
por: Zhang, Yan, et al.
Publicado: (2013)

Prediction and evaluation of high-risk patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy: an early criterion
por: Yang, Chunmei, et al.
Publicado: (2022)

Non-invasive neuromodulation: an emerging intervention for visceral pain in gastrointestinal disorders
por: Alam, Md Jahangir, et al.
Publicado: (2023)

Transcutaneous Vagal Nerve Stimulation (tVNS): a new neuromodulation tool in healthy humans?
por: Van Leusden, Jelle W. R., et al.
Publicado: (2015)

Neural Substrates of Transcutaneous Spinal Cord Stimulation: Neuromodulation across Multiple Segments of the Spinal Cord
por: Barss, Trevor S., et al.
Publicado: (2022)

Concomitant Sjögren's Syndrome Was Not Associated with a Poorer Response or Outcomes in Ursodeoxycholic Acid-Treated Patients with Primary Biliary Cholangitis
por: Ni, Ping, et al.
Publicado: (2019)

Ursodeoxycholic Acid at 18–22 mg/kg/d Showed a Promising Capacity for Treating Refractory Primary Biliary Cholangitis
por: Xiang, Xinyu, et al.
Publicado: (2021)

Number needed to treat with ursodeoxycholic acid therapy to prevent liver transplantation or death in primary biliary cholangitis
por: Harms, Maren H, et al.
Publicado: (2020)

Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid
por: de Boer, Jan Freark, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rmbkjbhk85urja8rbcemspcisc